Effects of gut microbiota on atherosclerosis through hydrogen sulfide

Dan-Dan Gui1, Wen Luo1, Bin-Jie Yan1

  • 1Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, University of South China, Hengyang, 421001, China.

Insights

Gut microbiota imbalances may drive atherosclerosis via hydrogen sulfide (H2S) production. This review explores H2S as a novel therapeutic target for cardiovascular disease, focusing on atherosclerosis development.

Area of Science:

  • Cardiovascular Science
  • Microbiome Research
  • Gastroenterology

Background:

  • Cardiovascular diseases are a leading global cause of death.
  • Atherosclerotic cardiovascular disease (ASCVD) results from genetic and environmental factors.
  • Gut microbiota dysbiosis is linked to various health issues, including extraintestinal conditions.

Purpose of the Study:

  • To explore the role of gut microbiota in atherosclerosis development.
  • To investigate hydrogen sulfide (H2S) production by gut bacteria as a factor in atherosclerosis.
  • To identify H2S as a potential therapeutic target for atherosclerosis.

Main Methods:

  • Literature review on gut microbiota, H2S, and atherosclerosis.
  • Analysis of existing research on the cardiovascular functions of H2S.
  • Synthesis of evidence linking gut microbial H2S production to ASCVD pathogenesis.

Main Results:

  • Hydrogen sulfide (H2S) is a key gasotransmitter with significant cardiovascular roles.
  • H2S regulates blood pressure, angiogenesis, and cellular processes in the cardiovascular system.
  • Gut microbiota alterations can influence H2S levels, potentially impacting atherosclerosis.

Conclusions:

  • Gut microbiota may contribute to atherosclerosis through altered H2S production.
  • Targeting microbial H2S offers a novel therapeutic avenue for managing atherosclerosis.
  • Further research into the gut-cardiovascular axis and H2S is warranted.

Related Concept Videos

Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
181
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
363
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
960
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
868
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
653